CD38-Targeted (89)Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care. Ulaner GA, Lewis J, Landgren O. J Nucl Med 2025 Jan 30:jnumed.124.269393. doi: 10.2967/jnumed.124.269393.

Read + Share

Amedeo Smart

Independent Medical Education

Ulaner GA, Lewis J, Landgren O. CD38-Targeted (89)Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care. J Nucl Med 2025 Jan 30:jnumed.124.269393. doi: 10.2967/jnumed.124.269393.
PMID: 39884767